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Biomimetic graphene oxide-cationic multi-shaped gold 
nanoparticle-hemin hybrid nanozyme: Tuning 
enhanced catalytic activity for the rapid colorimetric 
apta-biosensing of amphetamine-type stimulants
Abstract
Amphetamine-type stimulants are a class of illicit drug that constitutes a worldwide problem to 
which intelligence agencies, first responders and law enforcement are tasked with identifying them 
in unknown samples. We report on the development of a graphene oxide (GO)-cationic multi-
shaped gold nanoparticle (AuNP)-hemin hybrid nanozyme as a new biomimetic catalytic-induced 
aptamer-based colorimetric biosensor platform for amphetamine (AMP) and methamphetamine 
(MAMP). GO was electrostatically bonded to cationic multi-shaped cetyltrimethylammonium 
bromide (CTAB)-AuNPs to form a GO-CTAB-AuNP hybrid nanozyme exhibiting enhanced 
catalytic activity in the presence of hemin. The binding of an MNS 4.1 anticocaine DNA aptamer 
on the GO-CTAB-AuNP-hemin nanozyme assembly and the subsequent catalytic oxidation by 




 ensured that the colorimetric reaction was 
tuned to selectively detect AMP and MAMP with high sensitivity. Under optimum experimental 
conditions, AMP and MAMP were quantitatively detected within 1 min with a detection limit of 
34.1 ng/mL and 28.6 ng/mL respectively. Selected substances and drugs, known to react positively 
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to Marquis and Mandelin reagents (used in AMP and MAMP presumptive testing) and well-known 
adulterants, were tested for their affinity to react with the aptamer-based GO-CTAB-AuNP-hemin 
peroxidase mimic biosensor. The deep blue colorimetric reaction, specific to AMP and MAMP 
detection, was used as the basis to affirm the selectivity of the aptamer-based GO-CTAB-AuNP-
hemin peroxidase mimic biosensor. We believe the colorimetric biosensor developed in this work 
demonstrates a promising new direction in presumptive testing for AMP and MAMP.
Keywords: Aptamer; Gold nanoparticle; Graphene oxide; Hemin; Peroxidase mimic
1 Introduction
The outcome of investigative cases relating to the illegal possession of illicit drugs is heavily dependent on test 
results which provide scientific evidence that the suspected person is in possession of the drug in question. 
Colour spot tests, more commonly referred to as presumptive tests, are useful in providing rapid qualitative 
identification that a controlled drug may be present in a sample, enabling prompt action at the point of seizure 
[1–3]. The production, consumption and commercialization of illicit substances remain a serious concern in 
most countries. Within the context of production and exploitation, amphetamine-type stimulants (ATS) such as 
methamphetamine (MAMP) and amphetamine (AMP) dominate the illicit drug market in many countries [4] 
where the amount of confiscated ATS has drastically increased in recent years [5–7].
Colorimetric spot test such as the Marquis, Simon's and Mandelin tests are the ‘gold’ standard test used in ATS 
presumptive analysis. However, despite their wide-spread use in forensic analysis, there have been several 
reports of false positive results generated from chemical analysis of everyday items such as Epsom salts [8] 
and Krispy Kreme crumbs [9]. The limitation of colour spot test was recently brought to light in a case where 
unknown heart-shaped drugs were seized in Italy and presumptively identified as ATS using the Marquis 
reagent. However, further confirmatory test unraveled the substances as containing methyltestosterone, 
methanedone and androgen steroids with no trace of ATS being present [10,11]. Poor sensitivity of the 
colorimetric test when there are low levels of target analogue may be a significant contributing factor to false 
negative results [12]. In addition, the handling of colour spot reagents also poses increased health risk as many 
of the chemicals being used are highly corrosive and toxic. There is therefore an increased interest in the 
development of highly selective, ultrasensitive, rapid and safe-to-use colour spot test for accurate on-site and 
point of seizure ATS detection and one avenue of exploration to address this lies in the use of nanotechnology-
based biosensors.
Over the last decade, nanomaterials-based artificial enzymes, known as nanozymes have emerged as a 
powerful alternative to naturals enzymes in various applications ranging from pollutant removal, stem cell 
growth, cancer diagnostics and biosensing [13–15]. In the field of biosensing particularly, nanozyme-based 





(MNPs) [19] and plasmonic nanoparticles NPs [20] as catalyst to catalyse the oxidation of a suitable substrate 




) have been exploited in several colorimetric assays [21–23]. Gold 
NPs (AuNPs), characterized by their surface plasmon resonance (SPR) absorption feature are known to change 
colour relative to their chemical state and this property has been exploited in colorimetric assays [24]. 
Graphene oxide (GO) on the other hand, is a water-soluble 2D carbon nanomaterial, characterized by sheets of 
arranged carbon atoms in a honeycomb-like lattice structure and characterized by oxygen functional moieties 
(e.g. epoxy, carbonyl, carboxyl and hydroxyl) [25]. Despite the peroxidase mimic activity of AuNPs and 
graphene, their catalytic efficiency in sensor technology can be enhanced further by forming hybrid 
nanostructures [26,27]. Additionally, the incorporation of hemin (iron protoporphyrin IX) in a peroxidase 
mimic assay can also aid catalytic enhancement of the sensor. Hemin, known as the active site in heme-
containing protein such as peroxidase, myglobin, hemoglobin and catalases [28], exhibits peroxidase-like 





To selectively target the analyte of interest, the incorporation of a receptor molecule within a nanozyme 
peroxidase mimic assay is an efficient way to achieve this. Aptamers are short single-stranded RNA or DNA 
sequences, capable of undergoing selective antigen interaction due to three-dimensional structure formation [
30]. Intermolecular interaction with the target of interest via aromatic ring stacking, hydrogen bonding or van 
der Waal forces is facilitated by the nucleic acid aptamer structure (which could be a loop, quadruplex motifs, 
pseudoknot or k-turn) [31]. Compared with traditional antibodies, aptamers exhibit greater thermal stability, 
longer shelf-lives with no loss of activity and can easily be transported and stored [32].
In this work, we report on a novel catalytic-enhanced peroxidase mimic biosensor for the colorimetric 
detection of AMP and MAMP using GO-multi-shaped cetyltrimethylammonium bromide (CTAB)-AuNPs 
hybrid nanozyme with DNA aptamer as a bioreceptor and hemin as a catalytic signal amplifier. GO was first 
bound to CTAB-AuNPs via electrostatic interaction to form a GO-CTAB-AuNP hybrid nanozyme complex. 
Then a DNA aptamer, specific to the target ATS was thereafter bound to the GO-CTAB-AuNP hybrid 
nanozyme surface to capture the target ATS. This was followed by the binding of hemin and the subsequent 




 to generate a deep blue colour specific to 
the target ATS. To the best of our knowledge, the aptamer-based GO-CTAB-AuNP-hemin peroxidase mimic 
biosensor for ATS is the first of its kind and can colorimetrically detect AMP and MAMP as individual 
compounds in ~1 minute (min) with high sensitivity and selectivity.
2 Experimental
2.1 Materials
± Methadone HCl (≥98%), acetylsalicylic acid, acetaminophen, silver nitrate (AgNO
3
), (+) MAMP 




 (30% w/w) in solution with stabilizer were 
purchased from Sigma Aldrich. Tris(hydroxymethyl)aminomethane was purchased from Formedium. 





O), graphite powder and potassium permanganate (KMnO
4
) were purchased 
from Thermo Fisher. 3,6-Diacetylmorphine and codeine HCl were purchased from lipomed. The thiolated 
DNA aptamer oligonucleotide: The AMP and MAMP-specific DNA aptamer with the nucleic acid sequence;
HSC
6
-5ˈ-ACGGTTGCAAGTGGGACTCTGGTAGGCTGGGTAATTTGG [33] was synthesized and purified 
by Eurofins. All other chemicals were used as received. The buffer solution used in this study was prepared in 
Milli-Q water.
2.2 Characterization
UV/vis absorption measurements were carried out on a Cary Eclipse (Varian) spectrophotometer. Transmission 
electron microscopy (TEM) measurements were performed on a JEOL JEM-1200EX operated at 80  kV. 
Scanning electron microscope (SEM) imaging was carried out using a JEOL JSM 7400F field emission SEM. 
Zeta potential measurements were carried out using a Brook haven Nanobrook Omni particle size and zeta 
potential analyser. Absorbance measurements were recorded on an 800 TS microplate absorbance reader from 
BioTek. The Raman spectra were collected using an in-house built microprobe system equipped with a 
continuous wave laser sources emitting at 633 nm, the Oriel MS257 monochromator fitted with the Andor 
Newton EMCCD detector TE cooled to −-70  °C. The backscattering configuration was used for the signal 
collection. The incident power on the samples was 7 mW. The spectra were recorded using a 40×x objective, a 
1 s accumulation time with a total of 10 accumulations.
2.3 Synthesis of multi-shape CTAB-AuNPs
Multi-shape CTAB-AuNPs were synthesized via the seed-mediated approach with modifications [34]. The 




O and 0.6 mL 
0.01 M NaBH
4
. Thereafter, 150 μμL of the seed solution was added into the growth solution containing a 
mixture of 10  mL 0.1  M CTAB, 0.4  mL 0.1  M ascorbic acid, 0.5  mL 0.004  M AgNO
3





O. The solution was stirred for few min and kept in the dark for ~24 hours. 
Purification of the NPs was carried out via centrifugation.
2.4 Synthesis of GO nanosheets
GO nanosheets were synthesized via the modified Hummers method [35,36]. Graphite oxide was firstly 
prepared by mixing 2.5 g graphite powder and 1.25 g NaNO
3





the graphite powder was thoroughly dispersed in the acidified solution, 7.5 g KMnO
4
 was added and the 
solution was kept in ice for ~2 h and subsequently stirred for ~24 h at room temperature. The reaction mixture 
was then placed in an ice bath and 75 mL of Milli-Q water was added slowly. The reaction mixture was 





. Graphite oxide was thereafter purified by centrifugation with 5% HCl followed by acetone and dried in 
the fume hood. Graphite oxide was exfoliated to GO via ultrasonication.
2.5 Bioassay procedure
NaAc-KAc-KCl-HCl is a novel buffer solution developed in this work and was used as the choice buffer for 
the ATS catalytic assay. It was prepared by mixing 0.25 g NaAc, 0.25 g KAc, and 0.37 g KCl in 50 mL of 
MilliQ water. Then, 6.7 mL 0.1 M HCl was added into the 50 mL buffer solution and made up to 100 mL with 
MilliQ water and the pH of the solution was adjusted to 2.2. Electrostatic interaction between GO nanosheets 
and CTAB-AuNPs was formed by mixing 0.2  mg/mL GO with 0.04  nM CTAB-AuNPs. The final 
concentration of the GO-CTAB-AuNP hybrid was 0.03 nM. Thereafter, 40 μμL of GO-CTAB-AuNP hybrid 
solution was mixed with 5 μμL DNA aptamer (100 μμM), 150 μμL of target ATS concentration in KCl-HCl-




 (1.2 M) in 




 using a BioTek 




Graphene, known to be conceptually flat, is characterized by an sp2 trigonal-bonded hybridized array of 
carbon atom sheets. It is typically synthesized by chemical exfoliation of graphite oxide under strong oxidative 
and acidic reaction conditions and is characterized by oxygen atoms that are embedded in functional groups 
such as carboxyls, hydroxyls, epoxides and esters which lie both on the graphene sheet edges and on the basal 
plane [37,38]. GO is stabilized as a colloidal solution in water and is rendered negatively charged when the 
groups at the sheet edges, particularly carboxyl groups are ionized [37]. Fig. 1A and B shows the SEM images 
of GO and GO-CTAB-AuNP nanohybrid. From Fig. 1A, GO is characterized by crumpled thin and randomly 
aggregated flaky sheets, stacked together with observed folding and wrinkles. The corresponding GO-CTAB-
AuNP nanohybrid SEM image shown in Fig. 1B, revealed the retained morphology of GO and the embedded 




TEM analysis was used to further probe the surface morphology of GO, GO-CTAB-AuNP nanohybrid and the 
positively charged CTAB-AuNPs.  Fig. 1 C shows that the TEM micrograph of GO is characterized by well-
exfoliated individual sheets without the presence of bulk aggregates. The TEM image of the multi-shaped 
CTAB-AuNPs ( Fig. 1 D) synthesized via the seed-mediated approach, reveals a well-dispersed size distribution 
and homogeneity with a mixture of cubic, spherical, star, bipyramidal, hexagonal and irregular-shaped 
particles. The formation of various shaped particles is understood to arise from the interplay between the 
growth kinetics and the faceting properties of the CTAB surfactant [ 34 ]. The average particle size of CTAB-
SEM images of (A) GO and (B) GO-AuNP nanohybrid. TEM images of (C) GO, (D) CTAB-AuNPs and (E) GO-AuNP 
nanohybrid.
AuNPs was 47 nm. The corresponding TEM image of GO-CTAB-AuNP is shown in Fig. 1E. From the TEM 
micrograph, anchored CTAB-AuNPs were seen embedded within the sheet layer of GO, thus revealing the 
strong binding interaction between GO and CTAB-AuNPs.
3.2 Optical properties
3.2.1 UV/vis absorption
The optical properties of AuNPs are known to be determined by the presence of SPR absorption band. Any 
change in the geometry, shape or size of the particles influences the local electron confinement, resulting in 
alterations of the SPR band position and consequently the colour change of the colloidal solution [39,40]. Fig. 
2A shows that the multi-shaped CTAB-AuNPs solution is characterized by a distinctive SPR absorption band 
peaked at ~570 nm. Due to the altered shape of the NPs, the SPR band of the synthesized colloidal solution 
appears to be red-shifted compared with that of Au nanospheres (peaked at a wavelength of ~520 nm) and 
blue-shifted to that of anisotropic Au nanorods (>600 nm) [41]. The inset of Fig. 2A shows the strong purple 
colloidal solution of the synthesized CTAB-AuNPs. For GO (Fig. 2B), the characteristic sharp absorption peak 
at ~279 nm is assigned to the π → π* transition of the sp2 C =C bond [42] while the broad peak shoulder at 





The amount of work needed to move a unit positive charge (without acceleration) with affinity to the NP 
surface is reflected in the electric field potential. The electric field potential of a colloidal NP solution at the 
slipping/shear plane of an applied electric field is known as the Zeta potential. The adsorbed double layer, 
known as the electric double layer (EDL) is created on the NP surface when the colloidal NP solution is 
dispersed in solution. The EDL inner layer is embedded with ions/molecules having opposite charge to the 
colloidal NP solution. Therefore, the principle of Zeta potential relates to the difference in the electric field 
potential between the surrounding layer of dispersant and the EDL of an electrophoretic mobile particle [ 44 ]. 
The Zeta potential of GO and CTAB-AuNPs were measured to confirm the surface charge of the respective 
nanomaterials. From Fig. 2 C, the Zeta potential curves reveal the negative charge potential of GO with a Zeta 
potential charge of −-27.61  mV and the positive charge potential of CTAB-AuNPs with a Zeta potential 
charge of +46.49 mV.
3.2.3 Raman analysis
UV/vis absorption spectra of (A) multi-shaped CTAB-AuNPs and (B) GO nanosheet. ZP curve (C) and Raman spectra (D) of GO 
and CTAB-AuNPs. Inset of Fig. 2B = picture of CTAB-AuNPs in solution and inset of Fig. 2C = picture of GO in solution.
The Raman spectra of GO and GO-CTAB-AuNP shown in Fig. 2D are characterized by two distinct bands 
known as the D and G band [45]. For GO, the peak at 1325 cm−1 is ascribed to the D band and it arises due to 
the reduction in size of the sp2 domain plain induced from strong oxidation of graphene nanosheets. The 
second peak at 1590 cm−1 is ascribed to the G band and it arises from the E
2g
 first-order scattering [45]. An 
increase in intensity and a slight shift of the D (1336 cm−1) and G band (1596 cm−1) to higher wavenumbers 
was observed for the GO-CTAB-AuNP nanohybrid relative to GO. The observed change can be attributed to 
the electrostatic binding interaction between GO and CTAB-AuNPs. Prior to the electrostatic binding 




) for GO was 1.01 but decreased slightly to 0.98 for the GO-CTAB-AuNP 
nanohybrid.
3.3 Catalytic activity
The peroxidase mimic activity of the aptamer-based GO-CTAB-AuNP-hemin biosensor in inducing a catalytic 
colour reaction for the target ATS was investigated. From the UV/vis absorption data (Fig. 3A and B), no 









and GO-CTAB-AuNP + AMP. However, we observed a weak catalytic response when the GO-CTAB-AuNP 




 but without the catalytic 
amplifying effect of hemin in the biosensor system. With hemin incorporated into the catalytic biosensor 
system, a strong catalytic signal and blue colorimetric reaction, characterized by a distinct absorption peak at 
~660 nm, was observed for both AMP and MAMP. It is evident that the strong colorimetric and corresponding 
catalytic response can be attributed to the signal-enhancing effect of hemin in the biosensor system.
alt-text: Fig. 3
Fig. 3
To confirm the catalytic-enhancing property of the hybrid nanozyme, the catalytic signal of GO, CTAB-AuNPs 
and the GO-CTAB-AuNP hybrid nanozyme to MAMP detection was investigated under the same experimental 
condition.  Fig. 3 C shows that the GO-CTAB-AuNPs hybrid nanozyme induced higher catalytic signal for the 
detection of MAMP in comparison to the signal obtained for GO and CTAB-AuNPs. From the data, it is 
tentative that the combined catalytic activity of GO and CTAB-AuNPs, embedded within the hybrid nanozyme 
system, induced the enhanced catalytic signal. Thus, the sensitivity of the biosensor to MAMP detection was 
enhanced when GO-CTAB-AuNPs hybrid was used as the nanozyme catalyst.
The working principle of the aptamer-based GO-CTAB-AuNP-hemin peroxidase mimic catalytic biosensor for 
ATS detection is presented in  Scheme 1 . In general, peroxide-like activity of nanozymes using DNA aptamers 
as affinity receptors have been reported by several groups [ 46–49 ]. The mechanism of peroxidase-like catalytic 




 to hydroxyl radicals by 
the nanozyme catalyst [ 25]. Firstly, negatively charged GO is bound to the positively charged CTAB-AuNPs 
via electrostatic interaction. Thereafter, a thiolated DNA aptamer specific to the target ATS was adsorbed onto 
the GO-CTAB-AuNP surface via either DNA base stacking with GO hydrophobic domains, electrostatic 
repulsion with GO oxygen-rich domains or hydrogen bonding. Studies have also shown that the pyrimidine 
(A) Photographic colorimetric picture and (B) corresponding UV/vis absorption spectra of (i) TMB/H2O2 , (ii) GO-
AuNPs + TMB/H2O2 , (iii) GO-AuNPs + AMP, (iv) GO-AuNPs + DNA aptamer + AMP + TMB/H2O2 , (v) GO-AuNPs + DNA 
aptamer + MAMP + TMB/H2O2 , (vi) GO-AuNPs + DNA aptamer + AMP + hemin + TMB/H2O2  and (vii) GO-AuNPs + DNA 
aptamer + MAMP + hemin + TMB/H2O2 . (C) Enhanced catalytic signal of the GO-CTAB-AuNP hybrid to MAMP detection in 
comparison to CTAB-AuNPs and GO. [ATS] = 100 μμM. Reaction carried out at room temperature.
bases (C and T) bind more strongly to GO than the purine bases (G and A), suggesting the possibility that 
aromatic-based stacking interactions can occur with the bonded GO [50]. To enhance the binding interaction, 
the DNA aptamer was thiolated to provide the possibility of additional adsorption binding to the CTAB-AuNP 
surface. The target ATS drug was then added to the biosensor system and captured by the DNA aptamer 
followed swiftly by the addition of hemin. Hemin binds strongly to graphene via π-π interaction and was used 
to enhance the catalytic signal of the biosensor. TMB was then added into the aptamer-GO-CTAB-AuNP-





leading to the generation of colored blue product that corresponds selectively to the concentration of the 
detected ATS drug.
3.4 Optimization
3.4.1 Buffer and pH effect
alt-text: Scheme 1
Scheme 1
Schematic representation of the hybrid nanozyme peroxidase mimic aptamer-based biosensor for ATS detection. GO is first bound 
to CTAB-AuNP via electrostatic interaction to form a GO-AuNP hybrid nanozyme complex. Thereafter, the DNA aptamer is 
bound to the GO-AuNP hybrid nanozyme and captures the target ATS. Hemin is added to the system to enhance the catalytic 
signal followed by the catalytic oxidation of TMB by H2O2 , generating a blue colour complex specific to the target ATS 
concentration.
pH stabilization during enzymatic assays can be accomplished with a buffer solution while the buffer 
components can influence optimum catalytic efficiency. The term “Good buffers” was coined to represent 
certain buffers which demonstrated a catalytic stabilizing effect on the enzymatic assay [51]. Finding the 
appropriate buffer for optimum catalytic efficiency is quite challenging due to the varying degree of analyte 
interactions for each enzyme assay. To find the appropriate buffer for the targeted ATS detection, we probed 
the catalytic sensitivity of the aptamer-based GO-CTAB-AuNP-hemin hybrid biosensor in the presence of five 
different buffer solutions (Fig. 4A). From our investigation, we found that NaAc-KAc-KCl-HCl, pH 2.2 
buffer, a novel buffer developed in this work, induced an optimum catalytic signal for AMP and MAMP 
detection. Hence, this buffer was chosen as the buffer of choice for the ATS catalytic peroxidase mimic assay.
Subsequently, the effect of pH on the catalytic response of the peroxidase mimic biosensor to AMP and 
MAMP detection was studied.  Fig. 4 B shows the catalytic response of the aptamer-based GO-CTAB-AuNP-
hemin hybrid biosensor to AMP and MAMP in the pH range 2.2–5.0. From the data, optimum catalytic 
response was observed at pH 2.2, this then decreased at pH 2.6 and increased steadily to pH 3.8 for MAMP 
and pH 4.0 for AMP and finally, the catalytic response decreased steadily up until pH 5.0. Based on the 
observed data, pH 2.2 was chosen as the optimum pH condition for the catalytic assay.
alt-text: Fig. 4
Fig. 4
Catalytic response of the aptamer-based GO-CTAB-AuNP-hemin hybrid nanozyme to AMP and MAMP detection in different 
buffer solutions (A) and at different pH conditions (buffer: NaAc-KAc-KCl-HCl, pH 2.2) (B). GO-CTAB-AuNP hybrid nanozyme 
(0.03 nM); 100 μμM DNA aptamer; 100 μμM ATS; 100 μμM hemin; 3000 μμM TMB; 1.2 M H2O2 .
3.4.2 Effects of GO and CTAB-AuNPs concentration
The effect of GO concentration on the catalytic efficiency of the aptamer-based GO-CTAB-AuNP-hemin 
peroxidase mimic biosensor for AMP and MAMP detection was studied. Fig. 5A shows the catalytic response 
obtained for AMP and MAMP detection at different GO concentration. From the data, we observe a slight 
decrease in catalytic signal relative to increasing concentration of GO. The absorption spectra showing the 
effect of GO on the SPR absorption peak of CTAB-AuNPs was also studied. As shown in , we found 
the intensity of the SPR absorption peak decreased as the concentration of GO increased. Based on these 




Catalytic response of the aptamer-based GO-AuNP-hemin peroxidase mimic biosensor to MAMP and AMP detection at different 
(A) GO and (B) hemin concentrations. UV/vis absorption spectra showing the catalytic response of the peroxidase mimic 
biosensor to MAMP detection at different (C) TMB concentration (H2O2  concentration fixed) and (D) H2O2  concentration 
(TMB concentration fixed). GO-CTAB-AuNP hybrid nanozyme (0.03 nM); 100 μμM DNA aptamer; 100 μμM ATS; 100 μμM 
hemin; 3000 μμM TMB; 1.2 M H2O2 .
The effects of CTAB-AuNPs on the catalytic efficiency of the peroxidase mimic assay was also studied using 
AMP as the target drug. From , we observe that the catalytic signal of the peroxidase mimic biosensor 
increased as the concentration of CTAB-AuNPs increased. The absorption spectra ( ) also showed that 
the SPR absorption peak was influenced by the plasmonic NP concentration. From the observed data, we 
chose 0.04 nM CTAB-AuNPs as the choice concentration for the peroxidase mimic assay.
3.4.3 Effects of hemin concentration
Hemin was used as a catalytic signal enhancer for the peroxidase mimic biosensor. Hence, the effects of hemin 
concentration on the aptamer-based GO-CTAB-AuNP-hemin peroxidase mimic biosensor for AMP and 
MAMP detection was studied. A steady increase in catalytic signal was observed with increasing hemin 
concentration for AMP and MAMP detection as shown in Fig. 5B. Hence, 100 μμM hemin was chosen as the 
optimum concentration for enhanced catalytic reaction.









 concentration on the aptamer-based GO-CTAB-AuNP-hemin peroxidase mimic 
biosensor was studied. The catalytic signal to MAMP detection was probed in the presence of TMB 




 concentration from 0.2 to- 1.2 M. As shown in Fig. 5C and 














 had a more 
significant impact on the catalytic signal of the peroxidase mimic biosensor than an increasing concentration 




 were chosen as the optimum 
substrate and oxidant concentrations for the peroxidase mimic biosensor.
3.5 Nanozyme kinetic bioassay
Kinetic studies of the aptamer-based GO-CTAB-AuNP-hemin peroxidase mimic biosensor was carried out to 
reveal changes in the velocity of the reaction as a function of changes in the substrate concentration at a fixed 









 concentration (fixed TMB concentration), were used to determine the 
initial rate of reaction (v) (i.e., the slope of the graph), the value of v was then divided by the extinction 
coefficient of TMB (3.9 ⅹ  104  M−1  cm−1) [53]. The Michaelis-Menten nonlinear curve was obtained 















The linear curve was fitted by plotting   versus   ( ) according to the 
Lineweaver-Burke equation [ 52 ]:
V
max
 is the maximum reaction velocity, K
m
 is the Michaelis-Menten constant and [S] is the substrate 





was determined by multiplying the slope value with V
max
.













 is the measure of catalytic affinity between the hybrid nanozyme and substrate in which a low 
K
m
 value represents a strong affinity and vice versa; V
max
 is a measure of the catalytic rate of reaction in 
which a higher V
max
 value represents a higher catalytic rate of reaction; K
cat
 is the catalytic constant whose 





/[E], where E is the hybrid nanozyme concentration. From the kinetic assay results ( Table 
1 ), we observed a stronger affinity between the hybrid nanozyme and the substrate (TMB) for AMP detection 
based on the lower K
m
 value (0.24 mM) obtained compared to MAMP (K
m
 = 0.52 mM). However, the higher 
K
cat
 value obtained for MAMP detection (K
cat
 = 8.2 × 105 s −1 ) in the presence of TMB substrate, suggests 
there was higher amount of oxidized substrate generated per nanozyme per second relative to AMP 
(K
cat
 = 2.7 × 105 s−1). Generally, we observed a higher K
cat
 value for MAMP detection relative to AMP in 










 values for 
enzymatic catalytic reaction of MAMP and AMP using the novel GO-CTAB-AuNP-hemin hybrid nanozyme.




Km,  Vmax  and K cat  kinetic parameters of GO-CTAB-AuNP hybrid nanozyme for MAMP and AMP detection.
Drug [E] M Substrate V max  (M s
−1
) K m  (mM) K cat  (s
−1
)
MAMP 2.7 × 10−11 TMB 2.2 × 10−5 0.52 8.2 × 105
MAMP 2.7 × 10−11 H2O2 3.1 × 10
−5
1100 1.2 × 106
AMP 2.7 × 10−11 TMB 6.8 × 10−6 0.24 2.5 × 105
AMP 2.7 × 10−11 H2O2 8.5 × 10
−6
396 3.2 × 105
i The table layout displayed in this section is not how it will appear in the final version. The representation below is 
solely purposed for providing corrections to the table. To preview the actual presentation of the table, please 
view the Proof.
3.6 Quantitative detection of AMP and MAMP
Quantitative detection of AMP and MAMP using the aptamer-based GO-CTAB-AuNP-hemin peroxidase 
mimic biosensor was carried out in the concentration range of 0.5–100 μμM.  Fig. 6 A shows the quantitative 
colorimetric response of 0.5–100 μμM AMP and MAMP detection using the peroxidase mimic biosensor. 
From the colour reaction, we observed a clear change in the colour intensity as the detected concentration of 
AMP increased. Whereas for MAMP, the intensity of the colour reaction was less prominent but clearly 
distinguishable in the catalytic signal. The difference may be attributed to the very strong oxidation of TMB in 
the presence of MAMP. From  Table 1 , we observed that the K
cat
 value for MAMP in the presence of the 




 was higher than the value obtained for AMP. This proves to show that the aptamer-
based GO-CTAB-AuNP-hemin peroxidase mimic biosensor exhibits higher catalytic activity to MAMP than 
AMP.
The corresponding catalytic signal curve shown in  Fig. 6 B for AMP and  Fig. 6 C for MAMP revealed 
quantitative detection of the drug sample. As the concentration of the target ATS increased in the detection 
system, the catalytic signal progressively increased. From the linear calibration curve, we determined the limit 
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Fig. 6
Quantitative detection of the target AMP and MAMP. (A) Photographic colorimetric response and catalytic calibration plot for 
quantitative detection of AMP (B) and MAMP (C). Inset of  Fig. 7 B is the linear calibration curve for AMP detection. GO-CTAB-
AuNP hybrid nanozyme (0.03 nM); 100 μμM DNA aptamer; 100 μμM ATS; 100 μμM hemin; 3000 μμM TMB; 1.2 M H2O2 . 
Data recorded at ~1 min.
of detection (LOD) by multiplying the standard deviation of blank measurement by 3 and dividing by the slope 
of the linear calibration graph. The LOD obtained for AMP detection was 185 nM (34.1 ng/mL) and 154 nM 
(28.6 ng/mL) for MAMP detection. Table 2 shows the improved sensitivity of the peroxidase mimic biosensor 
over most published colorimetric data for AMP and MAMP detection. From the comparison (Table 2), the 
response time (~1 min) of our peroxidase mimic biosensor is the best reported to date.
3.7 Detection and quantitation of AMP in a seized sample
The efficacy of the aptamer-based GO-CTAB-AuNP-hemin peroxidase mimic biosensor was probed for the 
detection and quantitation of AMP in a seized drug sample.  shows the colorimetric response of the 
peroxidase mimic biosensor to different AMP concentrations within the sample. It is evident that the colour 
intensity increased steadily as the concentration of AMP increased. The corresponding quantitative catalytic 
signal curve presented in  revealed the steady increase in catalytic signal as the concentration of AMP 
increased. From the catalytic signal plot, we determined the LOD to be 187 nM (34.5 ng/mL) which was close 
to the LOD obtained for standard AMP sample (185 nM (34.1 ng/mL).
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Table 2
Comparison of the analytical performance of the aptamer-GO-CTAB-AuNP-hemin hybrid nanozyme biosensor probe for ATS 
detection with published data.














Au@Ag DNA aptamer probe MAMP Colorimetry 0.0149 ng/mL 15 min [ 56 ]
Simons reagent in sol-gel matrix MAMP Colorimetry 2.1 × 105–5.9 × 105  ng/mL 2 min [ 57 ]
Centrifugal microdevice MAMP Colorimetry 7.5 × 105  ng/mL 5 min [ 12 ]
G-quadruplex–hemin DNAzyme molecular 
beacon
MAMP Colorimetry 0.0746 ng/mL 10 min [ 58 ]
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3.8 Selectivity of the peoxidase-mimic bioassay
Marquis, Simon's and Mandelin reagents are the standard presumptive tests used in ATS analysis. Marquis and 
Mandelin reagents are specifically used for AMP and MAMP while Simon's reagent is used to differentiate 
between MAMP and AMP [54]. However, there are also several other substances that respond positively to 
both the Marquis and Mandelin reagents [55] and as such a more selective presumptive test designed 
specifically for AMP and MAMP would be very advantageous. To probe the selectivity of the peroxidase 
mimic biosensor to AMP and MAMP, known substances and drugs that respond positively to the Marquis and 
Mandelin reagents were tested.  provides information on the positive response of the tested drugs and 
substances to Marquis and Mandelin reagents and the colour they exhibit.
Fig. 7 shows the colorimetric response and catalytic signal obtained for AMP and MAMP in comparison to the 
data obtained for the tested substances and drugs. From the data, we observed a very strong catalytic signal for 
AMP and MAMP accompanied with a very deep blue colorimetric reaction. In contrast, a very weak catalytic 
response was exhibited by the additional tested substances and drugs which could be differentiated from the 
deep blue colour exhibited by AMP and MAMP. In terms of the catalytic signal efficiency, the AMP catalytic 
signal was 4-fold higher while MAMP was at most 5-fold higher than the catalytic signal obtained for the 
tested interferents. Based on our results, it is reasonable to conclude that the presumptive testing of AMP and 
MAMP can be selectively differentiated from other tested interferents by the rapid deep blue colour reaction 
transduced by the aptamer-based GO-CTAB-AuNPs peroxidase mimic biosensor.




Catalytic and corresponding colorimetric response of the aptamer-GO-AuNP-hemin hybrid nanozyme to AMP and MAMP in 
comparison to other tested drugs and substances. Concentration of ATS and other non-targets =  100 μμM; GO-CTAB-AuNP 
hybrid nanozyme (0.03 nM); 100 μμM DNA aptamer; 100 μμM hemin; 3000 μμM TMB; 1.2 M H2O2 . Data recorded at ~1 min.
The efficacy of the aptamer-based GO-CTAB-AuNP-hemin peroxidase mimic biosensor to detect the targeted 
ATS in mixed drug samples was investigated. Known adulterants such as acetaminophen, caffeine and 
ketamine were mixed with different concentration of MAMP and the analytical performance of the aptamer-
based nanohybrid peroxidase mimic biosensor was examined. Table 3 shows the recovery efficiency of the 
aptamer-based nanohybrid peroxidase mimic biosensor for the detection of 100, 60 and 20 μμM MAMP in a 
mixed sample solution containing a fixed concentration of added adulterant (100 μμM). From the data, the 
recovery efficiency was at most 79.3% for 100 μμM of added MAMP in acetaminophen, 78.8% for 20 μμM of 
added MAMP in caffeine and 79.6% for 60 μμM of added MAMP in ketamine. In general, we found out that 
the aptamer-based GO-CTAB-AuNP-hemin peroxidase mimic biosensor could detect MAMP in mixed drug 
samples with varying efficiency.
4 Conclusions
Negatively charged GO was electrostatically bonded to positively charged CTAB-AuNPs and the formed GO-
CTAB-AuNP hybrid nanozyme was employed in an aptamer-based peroxidase mimic biosensor assay for the 
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Table 3
Analytical performance of the aptamer-GO-CTAB-AuNP-hemin hybrid nanozyme peroxidase-like catalytic biosensor for MAMP 
detection in mixed drug samples. All data recorded at ~1 min.
Mixed drug (100 μμM) MAMP added (μM) Found (μM) Recovery (%) ±SD (%) RSD (%)
Acetaminophen
100 79.3 79.3 ± 4.7 4.7
60 36.5 60.8 ± 1.8 3.0
20 13.7 68.6 ± 0.9 1.7
Caffeine
100 70.9 70.9 ± 5.7 6.4
60 37.8 63.1 ± 0.4 0.6
20 15.8 78.8 ± 1.4 2.3
Ketamine
100 71.2 71.2 ± 1.9 2.0
60 47.8 79.6 ± 0.9 1.2
20 15.5 77.6 ± 0.3 0.4
SD = Standard deviation of three replicate measurements.
i The table layout displayed in this section is not how it will appear in the final version. The representation below is 
solely purposed for providing corrections to the table. To preview the actual presentation of the table, please 
view the Proof.
enhanced catalytic colorimetric detection of AMP and MAMP. Hemin, an iron-containing porphyrin complex 
was incorporated into the biosensor system and used as a catalytic signal amplifier. The structural and optical 
properties of GO, CTAB-AuNPs and the GO-CTAB-AuNP hybrid nanozyme were characterized using 
electron-based and optical techniques. Under the optimum reaction conditions, AMP and MAMP were 
quantitatively detected with high sensitivity and the selectivity of the biosensor was confirmed by the deep 
blue colour reaction specific to AMP and MAMP recognition.
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Graphical abstract
Highlights
• GO-multi-shaped cationic AuNP-hemin hybrid nanozyme was newly developed.
• An anti-ATS DNA aptamer was bonded to the hybrid nanozyme.
• Hemin was used as a catalytic-induced signal amplifier for the colorimetric assay.
• TMB catalyzed reaction of H2O2 by the aptamer-based hybrid nanozyme detected AMP and MAMP.
• The target drugs were detected within one minute with excellent selectivity and ultrasensitivity.
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